Articles

01/11/2021 A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

by M.Espi, X.Charmetant (...) and O.Thaunat, Kidney International 2021, DOI : 10.1016/j.kint.2021.10.040

Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes

Travel Med Infect Dis.

21/09/2021 Publication Equipe REVE. Manet et al. NAR

Modulation de l'épissage alternatif pendant l'infection précoce des lymphocytes B primaires humains par le virus d'Epstein-Barr (EBV) : une nouvelle fonction pour la protéine virale EBNA-LP.

14/09/2021 Nature communications : last LYACTS team publication

08/09/2021 The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis

Espi M, Charmetant X, et al, Kid Int 2021

Co-infection with Legionella and SARS-CoV-2, France, March 2020

C. Allam et al. Emerging Infectious Diseases Volume 27, Number 11—November 2021

09/08/2021 JEM, 2021, August 06 :Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs

Evidence for long-term association of virion-delivered Hepatitis B virus Core protein with cccDNA independently of viral protein production

Lucifora, Pastor et al., JHep Reports, 2021 / Team HepVir

07/07/2021 A breath of humanity in the era of Covid-19 vaccine

24/06/2021 Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response

ALPK1 gene mutations drive autoinflammation with ectodermal dysplasia and progressive vision loss

ALPK1 est une kinase qui détecte un métabolite bactérien de la voie de biosynthèse du LPS. Notre clinicien préféré décrit une nouvelle famille de patients. Cette maladie monogénique rare associée à une perte de vision est encore mal connue dans le domaine de l'autoinflammation et cette description d'une nouvelle famille de patients devrait sensibiliser aux symptômes inflammatoires associés à cette maladie.

Science Translational Medicine: UBIVE publication on Lassa fever vaccine

25/05/2021 Science Immunology : LYACTS team publication on MIS-C syndrome

09/05/2021 The Journal of Immunology : last publication LYACTS team